Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gervais

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|January 22, 2020
Acidic isoforms of Erwinase form part of the product: Correlation with clinical experienceDavid Gervais
Advances in Experimental Medicine and Biology|September 5, 2019
Quality Control and Downstream Processing of Therapeutic EnzymesDavid Gervais
World Journal of Microbiology & Biotechnology|September 26, 2019
What makes a good new therapeutic L-asparaginase?Angela Beckett, David Gervais
Investigational New Drugs|September 1, 2021
Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-AsparaginaseTapasvi Modi, David Gervais
Molecular Biotechnology|May 30, 2014
Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzymeDavid Gervais, Nicholas Foote
Analytical Biochemistry|August 19, 2014
Capillary isoelectric focusing of a difficult-to-denature tetrameric enzyme using alkylurea-urea mixturesDavid Gervais, Darryl King
Journal of Pharmaceutical and Biomedical Analysis|December 20, 2021
l-Asparaginase and HCP quantification by SWATH LC-MS/MS for new and improved purification step in Erwinia chrysanthemil-asparaginase manufactureTapasvi Modi, Sergio Regufe da Mota, David Gervais
The AAPS Journal|May 24, 2014
Measurement of subvisible particulates in lyophilised Erwinia chrysanthemi L-asparaginase and relationship with clinical experienceDavid Gervais, Tim Corn, Andrew Downer, et al.
Bioprocess and Biosystems Engineering|August 22, 2012
Validation of a 30-year-old process for the manufacture of L-asparaginase from Erwinia chrysanthemiDavid Gervais, Nigel Allison, Alan Jennings, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 16, 2017
Robust quantitation of basic-protein higher-order aggregates using size-exclusion chromatographyDavid Gervais, Andrew Downer, Darryl King, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Biologicals : Journal of the International Association of Biological Standardization|January 22, 2020
Acidic isoforms of Erwinase form part of the product: Correlation with clinical experienceDavid Gervais
Advances in Experimental Medicine and Biology|September 5, 2019
Quality Control and Downstream Processing of Therapeutic EnzymesDavid Gervais
World Journal of Microbiology & Biotechnology|September 26, 2019
What makes a good new therapeutic L-asparaginase?Angela Beckett, David Gervais
Investigational New Drugs|September 1, 2021
Improved pharmacokinetic and pharmacodynamic profile of a novel PEGylated native Erwinia chrysanthemi L-AsparaginaseTapasvi Modi, David Gervais
Molecular Biotechnology|May 30, 2014
Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzymeDavid Gervais, Nicholas Foote
Analytical Biochemistry|August 19, 2014
Capillary isoelectric focusing of a difficult-to-denature tetrameric enzyme using alkylurea-urea mixturesDavid Gervais, Darryl King
Journal of Pharmaceutical and Biomedical Analysis|December 20, 2021
l-Asparaginase and HCP quantification by SWATH LC-MS/MS for new and improved purification step in Erwinia chrysanthemil-asparaginase manufactureTapasvi Modi, Sergio Regufe da Mota, David Gervais
The AAPS Journal|May 24, 2014
Measurement of subvisible particulates in lyophilised Erwinia chrysanthemi L-asparaginase and relationship with clinical experienceDavid Gervais, Tim Corn, Andrew Downer, et al.
Bioprocess and Biosystems Engineering|August 22, 2012
Validation of a 30-year-old process for the manufacture of L-asparaginase from Erwinia chrysanthemiDavid Gervais, Nigel Allison, Alan Jennings, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 16, 2017
Robust quantitation of basic-protein higher-order aggregates using size-exclusion chromatographyDavid Gervais, Andrew Downer, Darryl King, et al.
Pageof 2